Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical and biological characterization of bipolar depression and optimization of treatment schemes
ChiCTR-TNRC-10001112Phase 4Completed
- Sponsor
- Guangzhou Municipal Science and Technology Bureau
- Start
- Aug 2007
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of lithium carbonate, valproic acid, lamotrigine, sertraline, citalopram and 6 more in bipolar disorder (BD) (2 arms), sponsored by Guangzhou Municipal Science and Technology Bureau. Primary endpoints: Manic/hypomanic episode and Clinical Global Impression overall efficacy. Started Aug 2007; status: completed.
02
Drugs
lithium carbonatevalproic acidlamotriginesertralinecitalopram
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on ChiCTR-TNRC-10001112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNRC-10001112.